Physician profile
William J Heim
NPI 1821087370
$370.04
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $14.95 · 2021: $11.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $118.01 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $36.72 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $31.26 | 2019 | |
| Daiichi Sankyo INC. | $19.95 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.64 | 2019 | |
| Merck Sharp & Dohme LLC | $16.53 | 2019 | |
| Pfizer INC. | $15.90 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $15.90 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.55 | 2019 | |
| Foundation Medicine, INC. | $14.81 | 2019 | |
| Seagen INC. | $14.68 | 2019 | |
| Janssen Biotech, INC. | $12.78 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Heim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.